- Email: [email protected]
CME Multiple Choice Questions
Continuing Medical Education CME Multiple Choice Questions
jsm_2617
1. Which of the following statements are false? a) Moisturizers are safe first-line treatments for vaginal atrophy for the breast cancer patient. b) There are randomized clinical trials showing safety of minimally absorbed local vaginal estrogen use for atrophy in breast cancer patients with vaginal dryness. c) Most women on aromatase inhibitors will demonstrate signs and symptoms of vaginal and vulvar atrophy. d) The data on sexual effects of Tamoxifen are mixed with some studies showing sexual complaints and others not confirming this data. e) Regular sexual activity has been shown to be beneficial in preventing vaginal atrophy. 2. Which of the following statements concerning medications is correct? a) Buproprion (Wellbutrin SR) has been shown to increase sexual desire, arousal, orgasm intensity, and overall sexual satisfaction. b) Many women who are taking selective serotonin reuptake inhibitors (SSRIs) to control hot flashes and other menopausal symptoms do not experience sexual side effects of these antidepressants. c) To date, Stage III clinical trial examining the efficacy and safety of testosterone gel have demonstrated concerning results with respect to cardiovascular safety and breast cancer risk. d) The use of PDE5 for the treatment of female arousal disorder has been gaining popularity, and emerging data shows a strong consistent benefit for sexual arousal and lubrication. e) PT 141 or bremelanotide is under development and in stage 2 clinical trials for sexual health concerns for women; however there
14
14..15
may be some safety concerns regarding hypercholesterolemia in treated patients. 3. Which statement is correct? a) Arginimax® for women has been extensively studied in the breast cancer population and has shown efficacy and safety in this population. b) The Eros clitoral stimulator has been shown to be more effective than a commercially available vibrator. c) The botanical feminine arousal oil Zestra has 2 clinical studies that have demonstrated augmentation of the genital arousal response for some patients. d) Natural oils like avocado, olive, and peanut oil cannot be used as lubricants because they typically irritate the sensitive vagina mucosa. e) Good clean love® and Slippery Stuff are excellent vaginal moisturizers that breast cancer patients can use safely. 4. Which of the following psycho-social approaches to counseling is useful for the woman after breast cancer? a) Couples counseling b) Cognitive behavioral therapy (CBT) c) Mindfulness-based therapy 5. Mindfulness-based meditation has been shown to reduce which of the following; a) Dyspareunia due to vaginal atrophy b) Internal locus of control c) Fear of recurrence d) None of the above 6. Younger women with breast cancer are interested in which of the following: a) Exercise to improve body image b) Sexual enhancement products c) Sensate focus exercises d) Medications to improve arousal
J Sex Med 2012;9:14–15
Continuing Medical Education
Overall evaluation of the activity a. Excellent b. Very good c. Good d. Fair e. Poor
What degree of confidence do you have that you will apply your new learning in your practice? 100% 75% 50% 25% 0%
Was this activity responsive to your needs? Yes No
What one change will you make in your practice based on this new learning?
Was this activity relevant to your practice? Yes No
This activity is designed for a maximum of 1 category 1 credit. You should only claim the number of credits you have earned based on the amount of time needed to complete this activity. How many credits are you claiming for this activity? a. 1 b. 0.75 c. 0.5 d. 0.25
Did this activity increase your knowledge and/or skills in delivering patient care? Yes No
List any topics you would find interesting and professionally relevant for future CME activities:
Please indicate your current profession: 䊐 Physician 䊐 Nurse 䊐 Physician Assistant 䊐 Other Healthcare 䊐 Nurse Practitioner Professional 䊐 Other
Address 2:
Name:
Postal Code:
Institution:
Country:
Address 1:
Email Address:
City: State:
An online version of this activity is now available. If you wish to receive credit for this activity, please refer to the website: www.wileyblackwellcme.com. Alternatively, this page can be sent by fax to Blackwell Futura Media Services, at (781)-338-8325. If you do not receive your certificate within 30 days of submission, please contact David Kempe, Editorial Program Coordinator, at dkempe@ wiley.com.
J Sex Med 2012;9:14–15
15
jsm_2617
1. Which of the following statements are false? a) Moisturizers are safe first-line treatments for vaginal atrophy for the breast cancer patient. b) There are randomized clinical trials showing safety of minimally absorbed local vaginal estrogen use for atrophy in breast cancer patients with vaginal dryness. c) Most women on aromatase inhibitors will demonstrate signs and symptoms of vaginal and vulvar atrophy. d) The data on sexual effects of Tamoxifen are mixed with some studies showing sexual complaints and others not confirming this data. e) Regular sexual activity has been shown to be beneficial in preventing vaginal atrophy. 2. Which of the following statements concerning medications is correct? a) Buproprion (Wellbutrin SR) has been shown to increase sexual desire, arousal, orgasm intensity, and overall sexual satisfaction. b) Many women who are taking selective serotonin reuptake inhibitors (SSRIs) to control hot flashes and other menopausal symptoms do not experience sexual side effects of these antidepressants. c) To date, Stage III clinical trial examining the efficacy and safety of testosterone gel have demonstrated concerning results with respect to cardiovascular safety and breast cancer risk. d) The use of PDE5 for the treatment of female arousal disorder has been gaining popularity, and emerging data shows a strong consistent benefit for sexual arousal and lubrication. e) PT 141 or bremelanotide is under development and in stage 2 clinical trials for sexual health concerns for women; however there
14
14..15
may be some safety concerns regarding hypercholesterolemia in treated patients. 3. Which statement is correct? a) Arginimax® for women has been extensively studied in the breast cancer population and has shown efficacy and safety in this population. b) The Eros clitoral stimulator has been shown to be more effective than a commercially available vibrator. c) The botanical feminine arousal oil Zestra has 2 clinical studies that have demonstrated augmentation of the genital arousal response for some patients. d) Natural oils like avocado, olive, and peanut oil cannot be used as lubricants because they typically irritate the sensitive vagina mucosa. e) Good clean love® and Slippery Stuff are excellent vaginal moisturizers that breast cancer patients can use safely. 4. Which of the following psycho-social approaches to counseling is useful for the woman after breast cancer? a) Couples counseling b) Cognitive behavioral therapy (CBT) c) Mindfulness-based therapy 5. Mindfulness-based meditation has been shown to reduce which of the following; a) Dyspareunia due to vaginal atrophy b) Internal locus of control c) Fear of recurrence d) None of the above 6. Younger women with breast cancer are interested in which of the following: a) Exercise to improve body image b) Sexual enhancement products c) Sensate focus exercises d) Medications to improve arousal
J Sex Med 2012;9:14–15
Continuing Medical Education
Overall evaluation of the activity a. Excellent b. Very good c. Good d. Fair e. Poor
What degree of confidence do you have that you will apply your new learning in your practice? 100% 75% 50% 25% 0%
Was this activity responsive to your needs? Yes No
What one change will you make in your practice based on this new learning?
Was this activity relevant to your practice? Yes No
This activity is designed for a maximum of 1 category 1 credit. You should only claim the number of credits you have earned based on the amount of time needed to complete this activity. How many credits are you claiming for this activity? a. 1 b. 0.75 c. 0.5 d. 0.25
Did this activity increase your knowledge and/or skills in delivering patient care? Yes No
List any topics you would find interesting and professionally relevant for future CME activities:
Please indicate your current profession: 䊐 Physician 䊐 Nurse 䊐 Physician Assistant 䊐 Other Healthcare 䊐 Nurse Practitioner Professional 䊐 Other
Address 2:
Name:
Postal Code:
Institution:
Country:
Address 1:
Email Address:
City: State:
An online version of this activity is now available. If you wish to receive credit for this activity, please refer to the website: www.wileyblackwellcme.com. Alternatively, this page can be sent by fax to Blackwell Futura Media Services, at (781)-338-8325. If you do not receive your certificate within 30 days of submission, please contact David Kempe, Editorial Program Coordinator, at dkempe@ wiley.com.
J Sex Med 2012;9:14–15
15